Global DNA methylation market size reached USD 7.79 billion in 2021 and is expected to register a revenue CAGR of 15.9% during the forecast period, according to latest analysis by Emergen Research. Rising usage of DNA methylation technology in oncology research is expected to drive market revenue growth between 2022 and 2030.
DNA methylation is a molecular biology technique widely used in the field of oncology research to detect chromosomal aberrations and mutations in the genome, due to the property of this technique to methylate the cytosine residues of DNA. DNA methylation is widely used as epigenetic biomarker to identify potential genetic mutations or genes that may develop cancer. Increasing prevalence of cancers and various other conditions has led to increased adoption of DNA methylation which is expected to further drive market revenue growth during the forecast period. DNA methylation technology has been adopted in various research initiatives and techniques such as DNA sequencing, genome-wide and gene-specific analyses, and others, which makes it one of the promising technologies in molecular biology. https://www.emergenresearch.co....m/industry-report/dn